Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a 12.509% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a. O=C(CC(Sc1ccc(Br)cc1)C(=O)O)c1ccc(Br)cc1
b. Cc1ccc(/C=N/NC(=O)CNC(=O)c2cccs2)cc1
c. N#CCSc1nc2sccc2c(=O)n1-c1ccccc1
Answer: c. N#CCSc1nc2sccc2c(=O)n1-c1ccccc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
N#CCSc1nc2sccc2c(=O)n1-c1ccccc1
N#CCSc1nc2sccc2c(=O)n1-c1ccccc1
2-(4-oxo-3-phenylthieno[2,3-d]pyrimidin-2-yl)sulfanylacetonitrile